Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac Disease
Clinical trial NCT03738475 · COMPLETED
Trial details
- NCT number
- NCT03738475
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-11
- Primary completion
- 2019-06-24
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.